Repeated infusions of CD3- or CD8-targeted NCs with CAR or T cell receptor (TCR) mRNA induced a sufficient number of T cells to express tumor-specific CARs or virus-specific TCR (22). The gene discussed is CD8A; the disease is neoplasm.